Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Sign In to gain access to subscriptions and/or personal tools.
Toxicologic Pathology
This Article
Right arrow Abstract Freely available
Right arrow Free Full Text (Free PDF) Free
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Robertson, J. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Robertson, J. L.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Journal Article

Chemically Induced Glomerular Injury: A Review of Basic Mechanisms and Specific Xenobiotics

John L. Robertson

Department of Biomedical Sciences and Pathobiology, Virginia—Maryland Regional College of Veterinary Medicine, Virginia Polytechnic Institute and State University, Blacksburg, Virginia 24091

Contact with many drugs and chemicals can produce glomerular injury. A common sign of such injury is proteinuria. Chemicals and drugs act through diverse mechanisms to produce injury, including direct damage to cellular and membranous glomerular components, as well as to renal vasculature. Several basic pathophysiologic mechanisms, including the "intact nephron hypothesis" and the "hyperfiltration hypothesis," help to explain the mode of toxicity of many chemicals. Furthermore, they provide a means to understand the basis for renal damage and the progression of renal disease once injury has occurred.

Key Words: Kidney • disease • models • drugs • chemicals • rats • humans

  • 1. Bondy G, Barker M, Mueller R, Fernie S, Miller JD, Armstrong C, Hierlihy SL, Rowsell P, and Suzuki C (1996). Fumonisin toxicity in male Sprague-Dawley rats. In: Fumonisins in Food. L Jackson, j DeVries, and L Bullerman (eds). Plenum Press, New York, pp. 251–264.
  • 2. Colvin BM, Coley AJ, and Beaver RV (1993). Fumonisin toxicosis in swine: Clinical and pathologic findings. J. Vet. Diagn. Invest. 5: 232–241.[Abstract/Free Full Text]
  • 3. Gumprecht LA, Marcucci A, Weigel RM, Vesonder RF, Riley RT, Showker JL, Beasley VR, and Haschek WM (1995). Effects of intravenous fumonisin B1 in rabbits: Nephrotoxicity and sphingolipid alterations. Nat. Toxins 3: 395–403.[CrossRef][Medline] [Order article via Infotrieve]
  • 4. Hashek WM, Motelin G, Ness DK, Karlin KS, Hall WF, Vesonder RF, Peterson RE, and Beasley VR (1991). Characterization of fumonisin toxicity in orally and intravenously dosed swine. Mycopathologia 117: 83–96.[CrossRef][Web of Science]
  • 5. Howard PC, Thurman JD, Lorentzen RJ, Voss KA, Bucci TJ, and Dooley KL (1995). The induction of apoptosis in the liver and kidneys of male and female rats fed diets for 28 days containing the mycotoxin fumonisin B1. Proc. Am. Assoc. Cancer Res. 36: 785.
  • 6. International Agency for Research on Cancer (IARC) (1993). Some naturally occurring substances: Food items and constituents. Heterocyclic aromatic amines and mycotoxins. Monographs on the Evaluation of Carcinogenic Risks to Humans, Vol. 56. IARC, Lyon, France.
  • 7. Kellerman TS, Marasas WFO, Thiel PG, Gelderblom WCA, Cawood ME, and Coetzer JAW (1990). Leukoencephalomalacia in two horses induced by oral dosing of fumonisin B1. Onderstepoort J. Vet. Res. 57: 269–275.[Web of Science][Medline] [Order article via Infotrieve]
  • 8. Kriek NPJ, Kellerman TS, and Marasas WFO (1981). A comparative study of the toxicity of Fusarium verticillordes (= F. moniliforme) to horses, primates, pigs, sheep and rats. Onderstepoort J. Vet. Res. 48: 129–131.[Web of Science][Medline] [Order article via Infotrieve]
  • 9. LaBorde JB, Terry KK, Howard PC, Chen JJ, Collins TFX, Shackelford ME, and Hansen DK (1997). Lack of embryotoxicity of fumonisin B1 in New Zealand White rabbits. Fund. Appl. Toxicol. 40: 120–128.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • 10. Marasas WFO (1996). Fumonisins: History, worldwide occurrence and impact. In: Fumonisin in Food. L Jackson et al (eds). Plenum Press, New York, pp. 1–17.
  • 11. Norred WP, Plattner RD, and Chamberlain WJ (1993). Distribution and excretion of [14C] fumonisin B1 in male Sprague-Dawley rats. Nat. Toxins 1: 341–346.[CrossRef][Medline] [Order article via Infotrieve]
  • 12. Norred WP, Voss KA, Riley RT, and Plattner RD (1996). Fumonisin toxicity and metabolism studies at the USDA. In: Fumonisins in Food. L Jackson, J DeVries, and L Bullerman (eds). Plenum Press, New York, pp. 225–236.
  • 13. Prelusky DB, Trenholm HL, and Savard ME (1994). Pharmacokinetic fate of 14C-labelled fumonisin B1 in swine. Nat. Toxins 2: 73–80.[CrossRef][Medline] [Order article via Infotrieve]
  • 14. Riley RT, An NH, Showker JL, Yoo H-S, Norred WP, Chamberlain WJ, Wang E, Merrill AH Jr, Motelin G, Beasley VR, and Haschek WM (1993). Alteration of tissue and serum sphinganine to sphingosine ratio: An early biomarker of exposure to fumonisin-containing feeds in pigs. Toxicol. Appl. Pharmacol. 118: 105–112.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • 15. Riley RT, Hinton DM, Chamberlain WJ, Bacon CW, Wang E, Merrill AH, and Voss KA (1994). Dietary fumonisin B1 induces disruption of sphingolipid metabolism in Sprague-Dawley rats. A new mechanism of nephrotoxiciy. J. Nutr. 124: 595–603.
  • 16. Riley RT, Norred WP, and Bacon CW (1993). Fungal toxins in foods: Recent concerns. Annu. Rev. Nutr. 13: 167–189.[Web of Science][Medline] [Order article via Infotrieve]
  • 17. Ross PF, Rice LG, Osweiller GD, Nelson PE, Richard JL, and Wilson TM (1992). A review and up-date of animal toxicoses associated with fumonisin-contaminated feeds and production of fumonisins by Fusarium isolates. Mycopathologia 117: 109–114.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • 18. Suzuki AM, Hierlihy L, Barker M, Curran I, Mueller R, and Bondy GS (1995). The effects of fumonisin B1 and several markers of nephrotoxicity in rats. Toxicol. Appl. Pharmacol. 133: 207–214.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • 19. Tolleson WH, Dooley KL, Sheldon WG, Thurman JD, Bucci TJ, and Howard PC (1995). The mycotoxin fumonisin induces apoptosis in cultured human cells and in livers and kidneys of rats. In: Fumonisin in Food. L Jackson, J DeVries, and L Bullerman (eds). Plenum Press, New York, pp. 237–250.
  • 20. Voss KA, Chamberlain WJ, Bacon CW, Herbert RA, Walters DB, and Norred WP (1995). Subchronic feeding study of the mycotoxin fumonisin B1 in B6C3F1 mice and Fischer 344 rats. Fund. Appl. Toxicol. 24: 102–110.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • 21. Voss KA, Chamberlain WJ, Bacon CW, and Norred WP (1993). A preliminary investigation on renal and hepatic toxicity in rats fed purified fumonisin B1. Nat. Toxins 1: 222–228.[CrossRef][Medline] [Order article via Infotrieve]
  • 22. Wang E, Norred WP, Bacon CW, Riley RT, and Merrell AH Jr (1991). Inhibition of sphingolipid biosyntheses by fumonisins and implications for diseases associated with Fusarium moniliforme. J. Biol. Chem. 266: 14486–14490.
  • 23. Wang E, Ross PF, Wilson TM, Riley RT, and Merrill AH Jr (1992). Alteration of serum sphingolipid upon dietary exposure of ponies to fumonisins, mycotoxins produced by Fusarium monilifonne. J. Nutr. 122: 1706–1716.
  • 24. Wilson TM, Ross PF, Owens DL, Rice LG, Jenkins SJ, and Nelson HA (1992). Experimental production of ELEM. A study to determine the minimum toxic dose in ponies. Mycopathologia 117: 115–120.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • 1. Abbate M, Macconi D, and Remuzzi G (1993). Mechanisms of glomerular injury. In: Toxicology of the Kidney, JB Hook and RS Goldstein (eds). Raven Press, Ltd., New York, pp. 153–200.
  • 2. Albini B, Glurich I and Andres GA (1984). Mercuric chloride-induced immunologically mediated diseases in experimental animals. In: Nephrotoxic Mechanisms of Drugs and Environmental Toxins, GA Porter (ed). Plenum Medical Book Co., New York, pp. 413–423.
  • 3. Alcorn D and Ryan GB (1981). Distribution of anionic groups in the glomerular capillary wall in rat nephrotoxic and aminonucleoside nephrosis. Pathology 13: 37–50.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • 4. Anderson S, Diamond JR, Karnovsky MJ, and Brenner BM (1988). Mechanisms underlying transition from acute glomerular injury to late glomerular sclerosis in a rat model of nephrotic syndrome. J. Clin. Invest. 82: 1757–1768.[Web of Science][Medline] [Order article via Infotrieve]
  • 5. Baldwin DS, Levine BB, McCluskey RT, and Gallo GR (1968). Renal failure and interstitial nephritis due to penicillin and methicillin. N. Engl. J. Med. 279: 1245–1252.[Web of Science][Medline] [Order article via Infotrieve]
  • 6. Bar-Khayim Y, Teplitz C, Garella S, and Chazan JA (1973). Trimethadione (tridione)-induced nephrotic syndrome. A report of a case with unique ultrastructural renal pathology. Am. J. Med. 54: 272–280.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • 7. Bernard A, Goret A, Roels H, Buchet JP, and Lauwerys R (1978). Experimental confirmation in rats of the mixed type proteinuria observed in workers exposed to cadmium. Toxicology 10: 369–375.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • 8. Brenner BM, Meyer TW, and Hostetter TH (1982). Dietary protein intake and the progressive nature of kidney disease. N. Engl. J. Med. 307: 652–672.[Web of Science][Medline] [Order article via Infotrieve]
  • 9. Bricker NS, Motrin PAF, and Kime SW (1960). The pathologic physiology of chronic Bright's disease: An exposition of the intact nephron hypothesis. Am. J. Med. 59: 77–98.
  • 10. Cohen AH, Mampaso F, and Zamboni L (1977). Glomerular podocyte degeneration in human renal disease. Lab. Invest. 37: 30–42.[Web of Science][Medline] [Order article via Infotrieve]
  • 11. Davies DJ, Dowling J, and Xipell JM (1977). Gold nephropathy. Pathology 9: 281–288.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • 12. Druet P, Sapin C, Druet E, and Hirsch F (1984). Genetic control of mercury-induced immune response in the rat. In: Nephrotoxic Mechanisms of Drugs and Environmental Toxins, GA Porter (ed). Plenum Medical Book Co., New York, pp. 425–435.
  • 13. English J, Evan A, Houghton DC, and Bennett WM (1987). Cyclosporin-induced acute renal dysfunction in the rat. Transplantation 44: 135–141.[Web of Science][Medline] [Order article via Infotrieve]
  • 14. Finkelstein A, Fraley DS, Feldman HA, Gandy DR, and Bourke E (1982). Fenoprofen nephropathy: Lipoid nephrosis and interstitial nephritis. A possible T-lymphocyte disorder. Am. J. Med. 72: 81–87.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • 15. Grieve EM, Hawksworth GM, Simpson JG, and Whiting PH (1990). Effect of thromboxane synthetase inhibition and angiotensin converting enzyme inhibition on acute cyclosporin A nephrotoxicity. Biochem. Pharm. 40: 2323–2329.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • 16. Harman JW (1971). Chronic glomerulonephritis and the nephrotic syndrome induced in rats with n,n'-diacetylbenzidine. J. Pathol. 104: 119–128.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • 17. Hertz P, Yager H, and Richardson JA (1972). Probenicid-induced nephrotic syndrome. Arch. Pathol. 94: 241–243.[Web of Science][Medline] [Order article via Infotrieve]
  • 18. Heymann W (1967). Nephrotic syndrome after use of trimethadione and paramethadione in petit mal. J. Am. Med. Assoc. 202: 127–128.
  • 19. Horvat R, Hovorka A, Dekan G, Poczewski H, and Kerjaschki D (1986). Endothelial cell membranes contain podocalyxin–-The major sialoprotein of visceral glomerular epithelial cells. J. Cell. Biol. 102: 484–491.[Abstract/Free Full Text]
  • 20. Jaffe IA, Treser G, Suzuki Y and Ehrenreich T (1968). Nephropathy induced by d-penicillamine. Ann. Int. Med. 69: 549–556.[Abstract/Free Full Text]
  • 21. Kean WF and Anastassiades TP (1979). Long term chrysotherapy. Incidence of toxicity and efficacy during sequential time periods. Arthritis Rheum. 22: 495–501.[Web of Science][Medline] [Order article via Infotrieve]
  • 22. Kerjaschki D, Vernillo AT, and Farquhar MG (1985). Reduced sialylation of podocalyxin–-The major sialoprotein of the rat kidney glomerulus–-In aminonucleoside nephrosis. Am. J. Pathol. 118: 343–349.[Abstract]
  • 23. Kirschbaum BB and Bosmann HB (1975). Studies of enzymes involved in glycoprotein synthesis and degradation in diacetylbenzidine nephrosis. J. Med. 6: 97–111.[Web of Science][Medline] [Order article via Infotrieve]
  • 24. Luck RG, Briggs JD, Fell GS, and Kennedy AC (1968). Proteinuria associated with d-penicillamine therapy of cystinuria. J. Urol. 99: 207–210.[Web of Science][Medline] [Order article via Infotrieve]
  • 25. Macadam RF (1969). The early glomerular lesion in human and rabbit lead poisoning. Br. J. Exp. Pathol. 50: 239–240.[Web of Science][Medline] [Order article via Infotrieve]
  • 26. Matthes KJ (1981). Drug-induced proteinuria. Contrib. Nephrol. 24: 109–114.[Medline] [Order article via Infotrieve]
  • 27. Medlock TR, von Hartitzsch B, and Ferris SA (1976). Lithium induced nephrotic syndrome. Kidney Int. 10: 547 (abstract).
  • 28. Myers BD, Newton L, Boshkos C, Macoviak JA, Frist WH, Derby GC, Perlroth MG, and Sibley RK (1988). Chronic injury of human renal microvessels with low-dose cyclosporin therapy. Transplantation 46: 694–703[Web of Science][Medline] [Order article via Infotrieve]
  • 29. Palosuo T and Milgrom F (1984). Gold-induced autoimmune reactions. In: Nephrotoxic Mechanisms of Drugs and Environmental Toxins, GA Porter (ed). Plenum Medical Book Co., New York, pp. 409–412.
  • 30. Perico N, Zoja C, Benigni A, Ghilardi F, Gualandris L, and Remuzzi G (1986). Effect of short-term cyclosporin administration in rats on renin–angiotensin and thromboxane A2: Possible relevance to the reduction in glomerular filtration rate. J. Pharmacol. Exp. Ther. 239: 229–235.[Abstract/Free Full Text]
  • 31. Portanova JP, Rubin RL, and Tan EM (1984). Antihistone antibodies induced by procainamide and hydralazine. In: Nephrotoxic Mechanisms of Drugs and Environmental Toxins, GA Porter (ed). Plenum Medical Book Co., New York, pp. 373–381.
  • 32. Radford MG, Holley KE, Grande JP, Larson TS, Wagoner RD, Donadio JV, and McCarthy JT (1996). Reversible membranous nephropathy associated with the use of non-steroidal antiinflammatory drugs. J. Am. Med. Assoc. 276: 466–469.[Abstract/Free Full Text]
  • 33. Remuzzi G and Perico N (1995). Cyclosporine-induced renal dysfunction in experimental animals and humans. Kidney Int. 48(suppl. 52): S70–S74.[Web of Science]
  • 34. Reynolds LR and Bhathena D (1979). Nephrotic syndrome associated with methimazole therapy. Ann. Int. Med. 139: 236–237.[CrossRef]
  • 35. Rizzoni G, Pavanello L, Dussini N, Chiandetti L, and Zacchello G (1979). Nephrotic syndrome during treatment with alpha-mercaptoproprionylglycine. J. Urol. 122: 381–382.[Web of Science][Medline] [Order article via Infotrieve]
  • 36. Robertson JL, Goldschmidt M, Kronfeld DS, Tomaszewski JT, Hill GS, and Bovee KT (1986). Long-term renal responses to high dietary protein in dogs with 75% nephrectomy. Kidney Int. 29: 511–519.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • 37. Robertson JL, Hill GS, and Streett CS (1997). Proteinuria and accelerated chronic progressive nephropathy in rats receiving histamine-2-receptor antagonists (unpublished).
  • 38. Rollason TP and Brewer DB (1984). A study of glomerular basement membrane anionic sites and glomerular visceral epithelial cell coat in protein overload proteinuria in the rat. J. Pathol. 142: 301–316.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • 39. Rossi NF, Churchill PC, McDonald FD, and Ellis VR (1989). Mechanism of cyclosporin A-induced renal vasoconstriction in the rat. J. Pharmacol. Exp. Ther. 250: 896–901.[Abstract/Free Full Text]
  • 40. Sadowski J, Potvliege PR, Gepts W, Storoukine M, and Lambert PP (1978). Urea-induced proteinuria: A new experimental model. Kidney Int. 13: 253–256.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • 41. Silverberg DS, Kidd EG, Shnitka TK, and Ulan RA (1970). Gold nephropathy. A clinical and pathologic study. Arthritis Rheum. 13: 812–825.[Web of Science][Medline] [Order article via Infotrieve]
  • 42. Sokol A, Bashner MH, and Okun R (1967). Nephrotic syndrome caused by probenicid. J. Am. Med. Assoc. 199: 101–102.
  • 43. Stein J and Smythe HA (1968). Nephrotic syndrome induced by penicillamine. Can. Med. Assoc. J. 98: 505–507.[Medline] [Order article via Infotrieve]
  • 44. Sturrock NDC, Lang CC, Coutie WJ, and Struthers AD (1995). Cyclosporin-induced renal vasoconstriction is augmented by frusemide and by angiotensin II in humans. J. Hypertension 13: 987–991.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • 45. Sussman HC, Fowler B, and Findley T (1968). Observations on the renal metabolism of protein in experimental and clinical nephrotic syndromes. Metabolism 17: 336–344.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • 46. Tornroth T and Skrifvars B (1974). Gold nephropathy–-Prototype of membranous glomerulonephritis. Am. J. Pathol. 75: 573–590.[Web of Science][Medline] [Order article via Infotrieve]
  • 47. Turk JL and Baker H (1968). Nephrotic syndrome due to ammoniated mercury. Br. J. Dermatol. 80: 623–624.[Medline] [Order article via Infotrieve]
  • 48. Weening JJ, Grond J, Van der Top D, and Hoedemaeker PJ (1980). Identification of the nuclear antigen involved in mercury-induced glomerulopathy in the rat. Invest. Cell Pathol. 3: 129–134.[Web of Science][Medline] [Order article via Infotrieve]
  • 49. Wilson CB (1984). Drug-and toxin-induced nephritides. Anti-kidney antibody and immune complex mediation. In: Nephrotoxic Mechanisms of Drugs and Environmental Toxins, GA Porter (ed). Plenum Medical Book Co., New York, pp. 383–392.
  • 50. Young BA, Burdmann EA, Johnson RJ, Andoh T, Bennett WM, Couser WG, and Alpers CE (1995). Cyclosporine A induced arteriolopathy in a rat model of chronic cyclosporine nephropathy. Kidney Int. 48: 431–438.[Web of Science][Medline] [Order article via Infotrieve]
  • 51. Zoja C, Furci L, Ghilardi F, Zilio P, Benigni A, and Remuzzi G (1986). Cyclosporin-induced endothelial cell injury. Lab. Invest. 55: 455–462.[Web of Science][Medline] [Order article via Infotrieve]

Toxicologic Pathology, Vol. 26, No. 1, 64-72 (1998)
DOI: 10.1177/019262339802600109
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
 Toxicol PatholHome page
N. Tsuchiya, M. Torii, I. Narama, and T. Matsui
Nephrotic Syndrome Induced by Dibasic Sodium Phosphate Injections for Twenty-eight Days in Rats
Toxicol Pathol, April 1, 2009; 37(3): 270 - 279.
[Abstract] [Full Text] [PDF]

Home page
 Toxicol PatholHome page
K. Kanki, T. Umemura, Y. Kitamura, Y. Ishii, Y. Kuroiwa, Y. Kodama, K. Itoh, M. Yamamoto, A. Nishikawa, and M. Hirose
A Possible Role of Nrf2 in Prevention of Renal Oxidative Damage by Ferric Nitrilotriacetate
Toxicol Pathol, February 1, 2008; 36(2): 353 - 361.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Renal Physiol.Home page
A. Nanez, N. F. Alejandro, M. H. Falahatpisheh, J. K. Kerzee, J. B. Roths, and K. S. Ramos
Disruption of glomerular cell-cell and cell-matrix interactions in hydrocarbon nephropathy
Am J Physiol Renal Physiol, December 1, 2005; 289(6): F1291 - F1303.
[Abstract] [Full Text] [PDF]

Home page
 Toxicol PatholHome page
J. C. Seely, J. K. Haseman, A. Nyska, D. C. Wolf, J. I. Everitt, and J. R. Hailey
The Effect of Chronic Progressive Nephropathy on the Incidence of Renal Tubule Cell Neoplasms in Control Male F344 Rats
Toxicol Pathol, October 1, 2002; 30(6): 681 - 686.
[Abstract] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Free Full Text (Free PDF) Free
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Robertson, J. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Robertson, J. L.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?